Edition:
United Kingdom

Ophthotech Corp (OPHT.OQ)

OPHT.OQ on NASDAQ Stock Exchange Global Select Market

2.69USD
20 Feb 2018
Change (% chg)

$-0.17 (-5.94%)
Prev Close
$2.86
Open
$2.83
Day's High
$2.83
Day's Low
$2.68
Volume
62,619
Avg. Vol
140,668
52-wk High
$4.60
52-wk Low
$2.24

Chart for

About

Ophthotech Corporation is a biopharmaceutical company. The Company is engaged in the development of therapeutics to treat ophthalmic diseases, with a focus on diseases of the back of the eye. Its primary focus is developing therapeutics for age-related macular degeneration (AMD), which is a disorder of the central portion of the... (more)

Overall

Beta: 1.48
Market Cap(Mil.): $92.37
Shares Outstanding(Mil.): 35.94
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 83.93 16.60
EPS (TTM): -- -- --
ROI: -- 1.66 10.66
ROE: -- 2.58 14.30

BRIEF-Ophthotech Q3 earnings per share $5.25

* Ophthotech reports third quarter 2017 financial and operating results

08 Nov 2017

BRIEF-Ophthotech recieves termination notice from Novartis Pharma

* Ophthotech-On oct 24, co received from Novartis Pharma notice terminating Licensing & Commercialization Agreement between parties dated May 19, 2014 Source text : (http://bit.ly/2gPty5O) Further company coverage:

27 Oct 2017

BRIEF-Ophthotech gives update on programs for treatment of eye diseases

* Ophthotech provides update on Zimura® complement programs for treatment of eye diseases

19 Sep 2017

Earnings vs. Estimates